313 related articles for article (PubMed ID: 22140255)
1. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.
Wang Z; Lai Y; Bernard JJ; Macleod DT; Cogen AL; Moss B; Di Nardo A
J Immunol; 2012 Jan; 188(1):345-57. PubMed ID: 22140255
[TBL] [Abstract][Full Text] [Related]
2. Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses.
Wang Z; MacLeod DT; Di Nardo A
J Immunol; 2012 Aug; 189(4):1551-8. PubMed ID: 22772452
[TBL] [Abstract][Full Text] [Related]
3. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.
Di Nardo A; Yamasaki K; Dorschner RA; Lai Y; Gallo RL
J Immunol; 2008 Jun; 180(11):7565-73. PubMed ID: 18490758
[TBL] [Abstract][Full Text] [Related]
4. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.
Howell MD; Gallo RL; Boguniewicz M; Jones JF; Wong C; Streib JE; Leung DY
Immunity; 2006 Mar; 24(3):341-8. PubMed ID: 16546102
[TBL] [Abstract][Full Text] [Related]
5. Group A
Clark M; Kim J; Etesami N; Shimamoto J; Whalen RV; Martin G; Okumura CYM
Front Immunol; 2018; 9():327. PubMed ID: 29535718
[TBL] [Abstract][Full Text] [Related]
6. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses.
Oskeritzian CA; Hait NC; Wedman P; Chumanevich A; Kolawole EM; Price MM; Falanga YT; Harikumar KB; Ryan JJ; Milstien S; Sabbadini R; Spiegel S
J Allergy Clin Immunol; 2015 Apr; 135(4):1008-1018.e1. PubMed ID: 25512083
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.
Domenico J; Lucas JJ; Fujita M; Gelfand EW
Int Arch Allergy Immunol; 2012; 158(2):196-205. PubMed ID: 22286752
[TBL] [Abstract][Full Text] [Related]
8. Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset.
Olivera A; Dillahunt SE; Rivera J
Immunol Lett; 2013 Feb; 150(1-2):89-96. PubMed ID: 23337656
[TBL] [Abstract][Full Text] [Related]
9. Mast Cell Cytonemes as a Defense Mechanism against Coxiella burnetii.
Mezouar S; Vitte J; Gorvel L; Ben Amara A; Desnues B; Mege JL
mBio; 2019 Apr; 10(2):. PubMed ID: 30992359
[TBL] [Abstract][Full Text] [Related]
10. Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.
Tian T; Dubin K; Jin Q; Qureshi A; King SL; Liu L; Jiang X; Murphy GF; Kupper TS; Fuhlbrigge RC
J Invest Dermatol; 2012 May; 132(5):1425-34. PubMed ID: 22318381
[TBL] [Abstract][Full Text] [Related]
11. Urticaria Neonatorum: accumulation of tryptase-expressing mast cells in the skin lesions of newborns with Erythema Toxicum.
Nelson A; Ulfgren AK; Edner J; Ståbi B; Brismar H; Hultenby K; Marchini G
Pediatr Allergy Immunol; 2007 Dec; 18(8):652-8. PubMed ID: 18078419
[TBL] [Abstract][Full Text] [Related]
12. Cytokines, skin, and smallpox-a new link to an antimicrobial Peptide.
Harrison JM; Ramshaw IA
Immunity; 2006 Mar; 24(3):245-7. PubMed ID: 16546093
[TBL] [Abstract][Full Text] [Related]
13. The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis.
Kraft S; Jouvin MH; Kulkarni N; Kissing S; Morgan ES; Dvorak AM; Schröder B; Saftig P; Kinet JP
J Immunol; 2013 Sep; 191(6):2871-8. PubMed ID: 23945142
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
Selin LK; Santolucito PA; Pinto AK; Szomolanyi-Tsuda E; Welsh RM
J Immunol; 2001 Jun; 166(11):6784-94. PubMed ID: 11359837
[TBL] [Abstract][Full Text] [Related]
15. Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response.
Bąbolewska E; Brzezińska-Błaszczyk E
Cell Immunol; 2015 Feb; 293(2):67-73. PubMed ID: 25577339
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin blocks mast cells and prevents rosacea like inflammation.
Choi JE; Werbel T; Wang Z; Wu CC; Yaksh TL; Di Nardo A
J Dermatol Sci; 2019 Jan; 93(1):58-64. PubMed ID: 30658871
[TBL] [Abstract][Full Text] [Related]
17. Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation.
Scott JE; ElKhal A; Freyschmidt EJ; MacArthur DH; McDonald D; Howell MD; Leung DY; Laouar A; Manjunath N; Bianchi T; Boes M; Oettgen HC; Geha RS
J Allergy Clin Immunol; 2007 Dec; 120(6):1382-8. PubMed ID: 17889291
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.
Di Nardo A; Vitiello A; Gallo RL
J Immunol; 2003 Mar; 170(5):2274-8. PubMed ID: 12594247
[TBL] [Abstract][Full Text] [Related]
19. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.
Howell MD; Jones JF; Kisich KO; Streib JE; Gallo RL; Leung DY
J Immunol; 2004 Feb; 172(3):1763-7. PubMed ID: 14734759
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes.
MacLeod DT; Nakatsuji T; Wang Z; di Nardo A; Gallo RL
J Invest Dermatol; 2015 Jan; 135(1):142-150. PubMed ID: 25089661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
